EMA: A CHANGE IN CHARACTER AS WELL AS POWERS?

ABSTRACT

[...]the latest development crosses a new frontier "Pharma companies need to focus more on R&D for innovative medicines against infections," it tweeted in mid-November. "Pharma companies need to boost research and development." EHU, as a brand, has yet to achieve enthusiastic endorsement from member states, who are suspicious of a stealthy power grab.